JP2022539400A5 - - Google Patents
Info
- Publication number
- JP2022539400A5 JP2022539400A5 JP2021578068A JP2021578068A JP2022539400A5 JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5 JP 2021578068 A JP2021578068 A JP 2021578068A JP 2021578068 A JP2021578068 A JP 2021578068A JP 2022539400 A5 JP2022539400 A5 JP 2022539400A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- bis
- biphenyl
- alkyl
- pentyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962870743P | 2019-07-04 | 2019-07-04 | |
| US62/870,743 | 2019-07-04 | ||
| US201962934318P | 2019-11-12 | 2019-11-12 | |
| US62/934,318 | 2019-11-12 | ||
| US202062966421P | 2020-01-27 | 2020-01-27 | |
| US62/966,421 | 2020-01-27 | ||
| PCT/CA2020/050932 WO2021000053A1 (en) | 2019-07-04 | 2020-07-03 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022539400A JP2022539400A (ja) | 2022-09-08 |
| JP2022539400A5 true JP2022539400A5 (cg-RX-API-DMAC10.html) | 2023-07-10 |
Family
ID=74100116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021578068A Pending JP2022539400A (ja) | 2019-07-04 | 2020-07-03 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12630492B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3994114A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022539400A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021000053A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| EP4243774A4 (en) * | 2020-11-16 | 2024-11-06 | Synergy Life Science, Inc. | Cannabinoid emulsifier |
| CN112898190B (zh) * | 2021-02-07 | 2023-10-24 | 中国科学院长春应用化学研究所 | 一种大麻二酚衍生物及其制备方法 |
| TWI894435B (zh) * | 2021-02-26 | 2025-08-21 | 日商丸善石油化學股份有限公司 | 縮醛化合物、含有該化合物之添加劑及含有該化合物之阻劑用組成物 |
| CN113087661B (zh) * | 2021-03-24 | 2022-09-06 | 福建省中科生物股份有限公司 | 一种2’,6’-双吡啶取代大麻二酚醚类化合物及其制备方法和用途 |
| CN113149897B (zh) * | 2021-03-24 | 2023-10-31 | 福建省中科生物股份有限公司 | 一种2,6-取代-4-氧基萜酚吡啶类化合物及其制备方法和用途 |
| CN115315418B (zh) * | 2021-04-06 | 2023-03-21 | 山东绿叶制药有限公司 | 大麻二酚前药及其药物组合物和应用 |
| AU2022324615A1 (en) * | 2021-08-04 | 2024-02-15 | Demeetra Agbio, Inc. | Cannabinoid derivatives and their use |
| CN116253671B (zh) * | 2021-12-10 | 2025-07-04 | 德义制药有限公司 | 一种大麻二酚衍生物及其制备方法和应用 |
| US20260193222A1 (en) * | 2022-12-02 | 2026-07-09 | Benethera (Shaoxing) Biotechnology Co., Ltd. | Compound and use thereof in treatment of treg-related diseases |
| WO2026038872A1 (ko) * | 2024-08-13 | 2026-02-19 | 주식회사 네오켄바이오 | 신규한 화합물 및 이의 용도 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643366A1 (de) * | 1967-10-04 | 1971-06-09 | Bayer Ag | Verfahren zur Herstellung von Phenol-Halbformalen |
| EP0119457B1 (de) | 1983-02-23 | 1986-12-30 | Bayer Ag | Mittel zur Regulierung des Pflanzenwachstums |
| DE3306201A1 (de) | 1983-02-23 | 1984-08-23 | Bayer Ag, 5090 Leverkusen | Mittel zur regulierung des pflanzenwachstums |
| EP1071419B1 (en) | 1998-04-21 | 2007-07-25 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Cannabinoids as antioxidants and neuroprotectants |
| US6566560B2 (en) * | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| US7285687B2 (en) | 2002-04-25 | 2007-10-23 | Virginia Commonwealth University | Cannabinoids |
| PT2473475T (pt) | 2009-08-31 | 2017-08-02 | Zynerba Pharmaceuticals Inc | Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas |
| WO2014039042A1 (en) | 2012-09-06 | 2014-03-13 | Northeastern University | Novel cannabinergic compounds and uses thereof |
| US9517989B2 (en) | 2012-10-17 | 2016-12-13 | Northeastern University | 2-cycloalkyl resorcinol cannabinergic ligands |
| JP6676176B2 (ja) | 2016-01-29 | 2020-04-08 | ユニヴァーシティー オブ ミシシッピ | 生物学的に活性なカンナビジオール類似体 |
| CN109311838A (zh) * | 2016-04-15 | 2019-02-05 | 蒂温诺特技术有限公司 | 大麻素前药的生物合成 |
| CN109069475B (zh) | 2016-04-22 | 2022-01-28 | 受体控股公司 | 快速作用植物类医药化合物和营养补剂 |
| JP2018162231A (ja) | 2017-03-27 | 2018-10-18 | 三井化学株式会社 | 遷移金属化合物、オレフィン重合用触媒およびオレフィン系重合体の製造方法 |
| WO2020107119A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use |
| CA3138732A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use |
| US20220242844A1 (en) | 2019-07-04 | 2022-08-04 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007659A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007660A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021062557A1 (en) | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US20230122510A1 (en) | 2019-11-26 | 2023-04-20 | Canopy Growth Corporation | Cannabinoid derivatives |
| US20230059582A1 (en) | 2019-12-09 | 2023-02-23 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-07-03 EP EP20828952.0A patent/EP3994114A4/en active Pending
- 2020-07-03 JP JP2021578068A patent/JP2022539400A/ja active Pending
- 2020-07-03 US US17/624,585 patent/US12630492B2/en active Active
- 2020-07-03 WO PCT/CA2020/050932 patent/WO2021000053A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505513A5 (cg-RX-API-DMAC10.html) | ||
| JP2022540432A5 (cg-RX-API-DMAC10.html) | ||
| JP2022540585A5 (cg-RX-API-DMAC10.html) | ||
| JP2022540434A5 (cg-RX-API-DMAC10.html) | ||
| JP2022551067A5 (cg-RX-API-DMAC10.html) | ||
| JP2022539401A5 (cg-RX-API-DMAC10.html) | ||
| JP2023503601A5 (cg-RX-API-DMAC10.html) | ||
| JP2022551066A5 (cg-RX-API-DMAC10.html) | ||
| JP2022540586A5 (cg-RX-API-DMAC10.html) | ||
| CN113365997A (zh) | 作为c-Met抑制剂的含嘧啶基团的三并环类化合物 | |
| CA3087912C (en) | Prodrugs of ketamine, compositions and uses thereof | |
| JP2023503331A5 (cg-RX-API-DMAC10.html) | ||
| RU2341515C2 (ru) | Ацетиленовые производные, способ их получения, фармацевтическая композиция на их основе и их применение в качестве антагонистов метаботропных глутаматных рецепторов (mglur5) | |
| JP2023503330A5 (cg-RX-API-DMAC10.html) | ||
| JP2015516420A5 (cg-RX-API-DMAC10.html) | ||
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| AR074184A1 (es) | Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah | |
| JP2022512482A5 (cg-RX-API-DMAC10.html) | ||
| NL1028087C2 (nl) | Sulfonamiderivaten voor de behandeling van ziekten. | |
| JP5342451B2 (ja) | Pde4阻害剤として有用な置換アセトフェノン | |
| CA2001160C (en) | Pyridine derivatives | |
| JP6813626B2 (ja) | グルコシルセラミド合成酵素阻害剤の製造方法 | |
| JP2016515096A5 (cg-RX-API-DMAC10.html) | ||
| SK284068B6 (sk) | Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie | |
| JP2022540433A5 (cg-RX-API-DMAC10.html) |